PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Symptom | |infection |
| Sentences | 498 |
| PubMedID- 20886072 | For infection with hepatitis c virus, the cultured jfh-1 strain was used. |
| PubMedID- 23758666 | Co-infection with hepatitis c and/or b is extremely common. |
| PubMedID- 23872239 | Chronic infection with hepatitis c virus (hcv) is a major global health problem; there are approximately 120 to 130 million chronic infections worldwide. |
| PubMedID- 24187444 | The infection with hepatitis c virus (hcv) is one of the most important global chronic viral infections worldwide. |
| PubMedID- 21113034 | This puts drug users at severe risk of infection with hiv, hepatitis c or other infections.29,30 discussions with law enforcement authorities on how to implement mmt within such settings needs to be addressed by creative measures. |
| PubMedID- 23874824 | Among the main causes of liver disease, co-infection with the hepatitis c (hcv) or hepatitis b (hbv) virus is the most frequent and has the worst prognosis 3. |
| PubMedID- 22574212 | Exclusion criteria were as follows: 1) lsm failure (no valid shots; n = 0), 2) invalid lsm defined as an interquartile range (iqr) to median value ratio (iqr/m) >0.3, success rate <60%, or <10 valid measurements; n = 6 , 3) a history of hepatic decompensation or antiviral treatment (n = 0), 4) co-infection with hepatitis c, hepatitis d, or hiv (n = 1), 5) heavy alcohol consumption (>30 g/day for >5 years; n = 4), 6) right-sided heart failure, ascites, or pregnancy (n = 0), 7) f0–2 fibrosis stage on lb (n = 20), 8) low viral load (<2,000 iu/ml; n = 7), 9) lb specimen shorter than 15 mm (n = 9), and 10) follow-up loss (n = 3) (figure s1). |
| PubMedID- 21722330 | Cv may occur as primary 'essential' vasculitis or - and much more frequently - as secondary vasculitis, mostly due to infection with the hepatitis c virus. |
| PubMedID- 20375957 | Conclusion: infection with hsv-2 and hepatitis c virus (hcv) was inversely associated with fars, independent of multiple confounders. |
| PubMedID- 23626742 | infection with hepatitis c virus and hepatitis b virus were tested in 30 and 28 cases, respectively. |
| PubMedID- 23338483 | infection with hepatitis c virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: implications for the management of hepatocellular carcinoma eligible for liver transplantation. |
| PubMedID- 20487539 | Testing for infection with hepatitis c (hcv) was added to the study protocol after 6 patients had been included. |
| PubMedID- 26357633 | Chronic infection with hepatitis c virus (hcv) carries a significant global health burden in both children and adults, with approximately 3% of the world's population infected. |
| PubMedID- 22107817 | Background: some, but not all, studies have demonstrated that dual infection with hepatitis c virus (hcv) and hiv has worse effects on cognition than infection with hiv alone. |
| PubMedID- 23097965 | Introduction: infection with hepatitis c is often manifested by a mild clinical course, and in many patients it is revealed incidentally, during routine laboratory ests. |
| PubMedID- 24651679 | Objective: infection with hepatitis c virus (hcv) or human immunodeficiency virus (hiv) may be associated with atherosclerosis and vascular disease. |
| PubMedID- 22263340 | Chronic infection with hepatitis c virus is a "silent epidemic", affecting 170 million people worldwide. |
| PubMedID- 26042425 | infection with the hepatitis c virus (hcv) is an important emerging public health issue for both developed and developing nations; an estimated 185 million people world-wide have been infected with hcv 1. |
| PubMedID- 24694258 | Coinfection with hepatitis c virus (hcv) worsens neurological functioning regardless of hiv infection status. |
| PubMedID- 20616580 | Persistent infection with hepatitis c virus (hcv) is a major risk toward development of hepatocellular carcinoma. |
| PubMedID- 22991587 | It could be suggested that the association between lichen planus and hepatitis c may result from infection with a particular form of hcv, a genotype found only in certain geographic areas. |
| PubMedID- 23270376 | Thus, infection in patients with chronic hepatitis c relapsers or non-responders to previous therapy has been an important public health problem and the possibility of an alternative to retreatment has been the focus of clinical investigations. |
| PubMedID- 22205621 | infection with hepatitis c virus (hcv) affects approximately 170 million people worldwide. |
| PubMedID- 24416632 | Apart from the effect of hiv, other variables also contribute significantly to oxidative stress in hiv-infected individuals, including co-infection with hepatitis c and alcohol use. |
| PubMedID- 23153151 | hepatitis c testing, infection, and linkage to care among racial and ethnic minorities in the united states, 2009-2010. |
| PubMedID- 26186636 | Chronic infection with the hepatitis c virus (hcv) is a cause of cirrhosis and hepatocellular carcinoma worldwide. |
| PubMedID- 24103591 | Following, we present diagrams of transition for treatment of chronic infection with hepatitis c virus in mutually excluding stages (figure 1). |
| PubMedID- 24886477 | In japan, an infection rate of the hepatitis c is high, and there are many hepatocellular carcinoma (hcc) cases. |
| PubMedID- 23936821 | Chronic infection with hepatitis c virus (hcv) affects almost 200 million people worldwide, representing a leading cause of cirrhosis and anticipated liver-related death 1. |
| PubMedID- 22911697 | in addition to traditional ckd risk factors such as diabetes and hypertension, co-infection with hepatitis c virus (hcv) has been suggested as a possible risk factor for ckd in hiv-positive individuals. |
| PubMedID- 22814930 | Cd40l is up-regulated on lymphocytes and cd40 on hepatocytes during infection with hepatitis c virus (hcv); we investigated the role of cd40 signaling during hcv replication in hepatocytes. |
| PubMedID- 22496645 | Physiologically relevant cell-culture models for infection with hepatitis c virus (hcv) are scarce, and infection by viruses derived from patient serum has been inefficient. |
| PubMedID- 22711689 | Persistent infection with hepatitis c virus (hcv) can lead to chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. |
| PubMedID- 20460924 | infection with hepatitis c virus (hcv) primarily causes chronic liver disease with characteristic histopathologic features, including hepatic steatosis. |
| PubMedID- 21167831 | By multivariate regression analysis, independent significant predictors for women to not achieve an svr were early menopause (odds ratio or, 8.055; 95% confidence interval ci, 1.834-25.350), levels of gamma-glutamyl transpeptidase (or, 2.165; 95% ci, 1.364-3.436), infection with hepatitis c virus genotype 1 or 4 (or, 3.861; 95% ci, 2.433-6.134), and cholesterol levels (or, 0.985; 95% ci, 0.971-0.998). |
| PubMedID- 22156972 | Objective: co-infection with hepatitis c virus (hcv) is a major cause of morbidity and mortality in hiv-infected individuals. |
| PubMedID- 23276803 | Hepatic fibrosis largely mediates this effect and infection with hepatitis c virus (hcv) is the most common cause. |
| PubMedID- 24463875 | Treatment of infection due to hepatitis c virus in haemodialysis. |
| PubMedID- 25562972 | infection with the hepatitis c virus (hcv) frequently causes chronic viral hepatitis, a major risk factor for the development of cirrhosis and hepatocellular carcinoma or primary liver cancer. |
| PubMedID- 23677838 | Osteoporosis is increasingly reported in the aging hiv-positive population, and co-infection with hepatitis c virus (hcv) may further increase the risk of osteoporosis. |
| PubMedID- 24340532 | The infection with hepatitis c virus (hcv) known also as a blood-borne infection can be life-threatening by delayed consequences of persistent infection. |
| PubMedID- 26075599 | Chronic infection with hepatitis c virus (hcv) is known as the major agent of chronic liver disease, hepatic cirrhosis, and hepatocellular carcinoma. |
| PubMedID- 24195978 | Patients were excluded if they fulfilled any of the following criteria: (i) co-infection with hepatitis c, hdv, or hiv; (ii) superimposed with other liver diseases; (iii) nonalcoholic steatohepatitis; (iv) previous immunosuppressive or antiviral therapy; (v) decompensated cirrhosis with a child–pugh score > 6, or evidence of portal hypertension, variceal bleeding, laboratory findings of a platelet count < 100 (109 /l), an international normalized ratio ≥ 1.3; (vii) creatinine > 135 micromol/l (viii) presence of hepatobiliary malignancy; (ix) alcohol consumption >20 g/day; and (x) organ transplantation. |
| PubMedID- 22310781 | Chronic infection with hepatitis c virus (hcv) is a major problem affecting a significant percentage of patients with end-stage renal failure (esrd), with a negative impact on patient survival, and associated with accelerated progression of liver damage after undergoing a kidney transplant. |
| PubMedID- 24454973 | Htlv-1 infection reduces clearance rates of hepatitis c virus and increases the risk of liver disease and liver disease-related deaths . |
| PubMedID- 25789012 | 1. overall, infection with hepatitis c virus (hcv) was the primary cause of liver disease (81%), followed by hbv (14%), hbv-hcv co-infection (3%) and other causes, such as those resulting from non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, hemochromatosis or those of a cryptogenic origin (2%). |
| PubMedID- 23840511 | Chronic infection with hepatitis c virus (hcv) is characterized by a broad spectrum of clinical manifestations that can culminate in decompensated cirrhosis. |
| PubMedID- 23114628 | Chronic infection with hepatitis c virus (hcv) is a major contributor to the high and rising incidence of hepatocellular carcinoma (hcc) worldwide (chen & morgan, 2006). |
| PubMedID- 22472296 | The results are shown in table 2. their medical histories showed that 15% (n = 6) of the treated group had co-infection with hepatitis c. there were no patients with a hepatitis c co-infection in the naïve group. |
| PubMedID- 22165497 | Co-infection with hepatitis c cannot be treated during pregnancy, since interferons are associated with a severe risk of fetal malformations and ribavirin has teratogenic effects; for this reason interferon therapy should be started after delivery. |